Skip to Content
Merck
CN
All Photos(1)

Key Documents

View All Documentation

Safety Information

A0773

Sigma-Aldrich

Angiotensin Converting Enzyme Inhibitor

≥95% (TLC)

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C53H76N14O12
CAS Number:
35115-60-7
Molecular Weight:
1101.26
MDL number:
MFCD00076208
UNSPSC Code:
12352200
PubChem Substance ID:
329770629
NACRES:
NA.77

biological source

synthetic (organic)

Quality Level

200

Assay

≥95% (TLC)

form

powder

mol wt

~_1.1 kDa

solubility

water: soluble 1 mg/mL, clear, colorless

storage temp.

−20°C

SMILES string

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(O)=O

InChI

1S/C53H76N14O12/c1-3-29(2)43(51(77)66-25-9-16-39(66)50(76)67-26-10-17-40(67)52(78)79)63-45(71)34(18-20-41(54)68)60-46(72)37-14-7-23-64(37)48(74)35(13-6-22-57-53(55)56)61-47(73)38-15-8-24-65(38)49(75)36(62-44(70)33-19-21-42(69)59-33)27-30-28-58-32-12-5-4-11-31(30)32/h4-5,11-12,28-29,33-40,43,58H,3,6-10,13-27H2,1-2H3,(H2,54,68)(H,59,69)(H,60,72)(H,61,73)(H,62,70)(H,63,71)(H,78,79)(H4,55,56,57)/t29-,33-,34-,35-,36-,37-,38-,39-,40-,43-/m0/s1

InChI key

UUUHXMGGBIUAPW-CSCXCSGISA-N

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

常规特殊物品

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000384622
0000356575
0000327215
0000384622
0000327215

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Of mice and men: therapeutic mTOR inhibition in polycystic kidney disease.
York Pei
Journal of the American Society of Nephrology : JASN, 21(3), 390-391 (2010-02-06)
Claudia Bello et al.
Bioorganic & medicinal chemistry, 18(9), 3320-3334 (2010-03-30)
Novel alpha-mannosidase inhibitors of the type (2R,3R,4S)-2-({[(1R)-2-hydroxy-1-arylethyl]amino}methyl)pyrrolidine-3,4-diol have been prepared and assayed for their anticancer activities. Compound 30 with the aryl group=4-trifluoromethylbiphenyl inhibits the proliferation of primary cells and cell lines of different origins, irrespective of Bcl-2 expression levels, inducing
Jung Keun Cho et al.
Bioorganic & medicinal chemistry letters, 21(10), 2945-2948 (2011-04-23)
The action of β-secretase is strongly tied to the onset of Alzheimer's disease. The development of inhibitors of β-secretase is thus critical to combating this disease, which threatens an ever increasing number of the population and grows in importance as
Karly C Sourris et al.
American journal of nephrology, 30(4), 323-335 (2009-06-27)
A commonality among the chemically disparate compounds that inhibit the formation and accumulation of advanced glycation end products (AGEs) or their signalling pathways is their end organ protection in experimental models of diabetes complications. Although this group of therapeutics are
Linqing Ma et al.
Journal of Alzheimer's disease : JAD, 27(1), 225-237 (2011-07-30)
Apomorphine hydrochloride (APO) is known to be a dopamine receptor agonist, and has recently been found to be a novel drug for Alzheimer's disease (AD). We found that APO treatment ameliorated oxidative stress in an AD mouse model and specifically
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service